House OKs drug safety bill

The House of Representatives passed a bill on Wednesday that backs new FDA authority over drug safety, including allowing the FDA to require new studies, order label changes and monitor drugs on the market. The bill also renews for five years two programs to collect user fees from drug and medical device manufacturers.

View Full Article in:

Google · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN